BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2171744)

  • 21. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines.
    Johnson BE; Makuch RW; Simmons AD; Gazdar AF; Burch D; Cashell AW
    Cancer Res; 1988 Sep; 48(18):5163-6. PubMed ID: 2842046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes.
    Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M
    Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.
    Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K
    Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer.
    Sekido Y; Takahashi T; Mäkelä TP; Obata Y; Ueda R; Hida T; Hibi K; Shimokata K; Alitalo K; Takahashi T
    Mol Cell Biol; 1992 Apr; 12(4):1747-54. PubMed ID: 1312669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of amplified c-myc and n-myc in small cell lung cancer cell lines.
    van der Hout AH; Kok K; van der Veen AY; Osinga J; de Leij LF; Buys CH
    Cancer Genet Cytogenet; 1989 Mar; 38(1):1-8. PubMed ID: 2540898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.
    Bergh JC
    Am Rev Respir Dis; 1990 Dec; 142(6 Pt 2):S20-6. PubMed ID: 2174659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.
    Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV
    Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis.
    Watson PH; Safneck JR; Le K; Dubik D; Shiu RP
    J Natl Cancer Inst; 1993 Jun; 85(11):902-7. PubMed ID: 8492318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A study of myc-related gene expression in small cell lung cancer by in situ hybridization.
    Gu J; Linnoila RI; Seibel NL; Gazdar AF; Minna JD; Brooks BJ; Hollis GF; Kirsch IR
    Am J Pathol; 1988 Jul; 132(1):13-7. PubMed ID: 2456019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice.
    Gazzeri S; Brambilla E; Jacrot M; Chauvin C; Benabid AL; Brambilla C
    Cancer Res; 1991 May; 51(10):2566-71. PubMed ID: 1850659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of the L-myc gene is under positive control by short-lived proteins.
    Saksela K
    Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
    Kiefer PE; Bepler G; Kubasch M; Havemann K
    Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
    Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cisplatin exposure on the degree of N-myc amplification in small cell lung carcinoma cell lines with N-myc amplification.
    Mizushima Y; Kashii T; Kobayashi M
    Oncology; 1996; 53(5):417-21. PubMed ID: 8784478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
    Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
    Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an inducible anti-sense c-myc gene transfer in a drug-resistant human small-cell-lung-carcinoma cell line.
    Van Waardenburg RC; Meijer C; Burger H; Nooter K; De Vries EG; Mulder NH; De Jong S
    Int J Cancer; 1997 Nov; 73(4):544-50. PubMed ID: 9389570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myc protein expression correlates with MYC amplification in small-cell lung carcinoma.
    Hwang DH; Sun H; Rodig SJ; Hornick JL; Sholl LM
    Histopathology; 2015 Jul; 67(1):81-9. PubMed ID: 25407018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amplification of oncogenes in lung carcinoma grafted in nude mice.
    Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL
    Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression.
    Kawate S; Fukusato T; Ohwada S; Watanuki A; Morishita Y
    Oncology; 1999; 57(2):157-63. PubMed ID: 10461064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.